Cargando…

Altered hypoxia inducible factor regulation in hereditary haemorrhagic telangiectasia

Patients with hereditary haemorrhagic telangiectasia (HHT), also known as Rendu–Osler–Weber syndrome, suffer from the consequences of abnormal vessel structures. These structures can lead to haemorrhages or shunt effects in liver, lungs and brain. This inherited and rare disease is characterized by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wrobeln, Anna, Leu, Tristan, Jablonska, Jadwiga, Geisthoff, Urban, Lang, Stephan, Fandrey, Joachim, Droege, Freya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988913/ https://www.ncbi.nlm.nih.gov/pubmed/35393474 http://dx.doi.org/10.1038/s41598-022-09759-9

Ejemplares similares

Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor Improves Leukocyte Energy Metabolism in Hereditary Hemorrhagic Telangiectasia
por: Schild, Yves, et al.
Publicado: (2023)

Impaired Release of Neutrophil Extracellular Traps and Anemia-Associated T Cell Deficiency in Hereditary Hemorrhagic Telangiectasia
por: Droege, Freya, et al.
Publicado: (2020)

Restless Leg Syndrome Is Underdiagnosed in Hereditary Hemorrhagic Telangiectasia—Results of an Online Survey
por: Droege, Freya, et al.
Publicado: (2021)

Trauma Can Induce Telangiectases in Hereditary Hemorrhagic Telangiectasia
por: Geisthoff, Urban, et al.
Publicado: (2020)

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)
por: Shovlin, Claire L., et al.
Publicado: (2018)

Nationwide Awareness Campaign and Call for Dental Screening for Hereditary Hemorrhagic Telangiectasia in Germany
por: Geisthoff, Urban W., et al.
Publicado: (2023)

Hereditary Hæmorrhagic Telangiectasia with Recurring Hæmaturia
por: Foggie, W. E.
Publicado: (1928)

Peliosis hepatis associated with hereditary haemorrhagic telangiectasia
por: Alessandrino, F., et al.
Publicado: (2013)

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia
por: de Gussem, E. M., et al.
Publicado: (2016)

Hereditary Haemorrhagic Telangiectasia: With Report of a Case
por: McEwan, Tom
Publicado: (1948)

Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia
por: Vorselaars, Veronique M. M., et al.
Publicado: (2018)

Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia
por: Major, Tamás, et al.
Publicado: (2019)

Hereditary haemorrhagic telangiectasia: A case report
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
por: Buscarini, Elisabetta, et al.
Publicado: (2019)

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
por: Zarrabeitia, Roberto, et al.
Publicado: (2017)

Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature
por: Dupuis, Olivier, et al.
Publicado: (2020)

Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
por: Shovlin, C. L., et al.
Publicado: (2019)

Endoglin is a conserved regulator of vasculogenesis in zebrafish – implications for hereditary haemorrhagic telangiectasia
por: Zhang, Ding, et al.
Publicado: (2019)

Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia
por: FIORELLA, M.L., et al.
Publicado: (2012)

Correction: Endoglin is a conserved regulator of vasculogenesis in zebrafish - implications for hereditary haemorrhagic telangiectasia
Publicado: (2021)

Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension
por: Sommer, N, et al.
Publicado: (2018)

Neurologic Manifestation as Initial Presentation in a Case of Hereditary Haemorrhagic Telangiectasia
por: Teo, Yeow Kwan, et al.
Publicado: (2010)

Long Non-Coding RNA Expression Profiles in Hereditary Haemorrhagic Telangiectasia
por: Tørring, Pernille M., et al.
Publicado: (2014)

Liver transplantation in a patient with hereditary haemorrhagic telangiectasia and pulmonary hypertension
por: Ejiri, Kentaro, et al.
Publicado: (2019)

Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience
por: Pagella, Fabio, et al.
Publicado: (2021)

Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions
por: Margelidon-Cozzolino, Victor, et al.
Publicado: (2021)

An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms
por: Arthur, Helen M., et al.
Publicado: (2022)

Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study
por: Delagrange, Laura, et al.
Publicado: (2022)

Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia
por: Chavan, Ajay, et al.
Publicado: (2012)

Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
por: Morales, Enrique, et al.
Publicado: (2012)

An update on the ophthalmic features in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
por: Abdolrahimzadeh, Solmaz, et al.
Publicado: (2022)

Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID‐19 pandemic
por: Gaetani, Eleonora, et al.
Publicado: (2020)

Therapeutic targeting of vascular malformation in a zebrafish model of hereditary haemorrhagic telangiectasia
por: Snodgrass, Ryan O., et al.
Publicado: (2023)

The bleeding diathesis in patients with hereditary haemorrhagic telangiectasia is not due to impaired platelet function
por: Lyster, Anne Lørup, et al.
Publicado: (2023)

European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)
por: Eker, Omer F., et al.
Publicado: (2020)

Endoplasmic Reticulum Quality Control Is Involved in the Mechanism of Endoglin-Mediated Hereditary Haemorrhagic Telangiectasia
por: Ali, Bassam R., et al.
Publicado: (2011)

Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls
por: Hosman, Anna E, et al.
Publicado: (2013)

Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia
por: Shovlin, Claire L., et al.
Publicado: (2016)

Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability
por: Revuz, Sabine, et al.
Publicado: (2017)

Life-threatening Anaemia in Patient with Hereditary Haemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome)
por: Mikołajczyk-Solińska, Melania, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2as5t91jeljhnj3ngt5j1kqo5u